CEL-SCI (CVM) said Wednesday it plans to offer to sell shares, and/or pre-funded warrants, in an underwritten public offering.
All of the shares, and/or warrants, are being offered by the company, it said.
The offering is subject to market conditions and there's no assurance as to whether or when it may be completed, or as to its size or terms, CEL-SCI said.
Net proceeds will be used to fund the development of Multikine, as well as for general corporate purposes, and working capital, the company said.
The company's shares were falling nearly 12% in recent after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.